Division of Nephrology, Tufts Medical Center, Boston, MA, USA.
Global Clinical Development, Amgen, Thousand Oaks, CA, USA.
Nephrol Dial Transplant. 2014 Jun;29(6):1195-203. doi: 10.1093/ndt/gft509. Epub 2014 Jan 20.
Glomerular filtration rate (GFR) estimating equations using the combination of creatinine and cystatin C (eGFRcr-cys) are more accurate than equations using either alone (eGFRcr or eGFRcys). New guidelines suggest measuring cystatin C as a confirmatory test when eGFRcr may be inaccurate, but do not specify demographic or clinical conditions in which eGFRcys or eGFRcr-cys are more accurate than eGFRcr nor which estimate to use in such circumstances.
We compared the performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations in 1119 subjects in the CKD-EPI cystatin C external validation dataset. Subgroups were defined by eGFRcr, age, sex, diabetes status and body mass index (BMI). The reference test was GFR measured using urinary or plasma clearance of exogenous filtration markers. Cystatin C and creatinine assays were traceable to primary reference materials. Accuracy was defined as the absolute difference in eGFR compared with mGFR.
The mean mGFR was 70 ± 41 (SD) mL/min/1.73 m(2). eGFRcys was more accurate than eGFRcr at lower BMI and less accurate at higher BMI, especially at higher levels of eGFRcr. There were small differences in accuracy in people according to the diabetes status. eGFRcr-cys was as accurate or more accurate than eGFRcr or eGFRcys in these and all other subgroups.
eGFRcr-cys, but not eGFRcys, is more accurate than eGFRcr in most subgroups we studied, suggesting preferential use of eGFRcr-cys when serum cystatin C is measured as a confirmatory test to obtain more accurate eGFR. Further studies are necessary to evaluate diagnostic strategies for using eGFRcys and eGFRcr-cys.
使用肌酐和胱抑素 C 组合的肾小球滤过率估计方程(eGFRcr-cys)比单独使用任何一种方程(eGFRcr 或 eGFRcys)更准确。新指南建议在 eGFRcr 可能不准确时,将胱抑素 C 作为确认性试验进行测量,但未具体说明在何种情况下 eGFRcys 或 eGFRcr-cys 比 eGFRcr 更准确,也未说明在这种情况下应使用哪种估计值。
我们比较了 1119 例 CKD-EPI 胱抑素 C 外部验证数据集中的慢性肾脏病流行病学合作组(CKD-EPI)方程的性能。亚组根据 eGFRcr、年龄、性别、糖尿病状态和体重指数(BMI)进行定义。参考测试是使用外源性滤过标志物的尿或血浆清除率测量的肾小球滤过率。胱抑素 C 和肌酐检测可追溯至初级参考物质。准确性定义为 eGFR 与 mGFR 的绝对差异。
平均 mGFR 为 70 ± 41(SD)mL/min/1.73 m(2)。在较低的 BMI 下,eGFRcys 比 eGFRcr 更准确,在较高的 BMI 下则不太准确,尤其是在较高水平的 eGFRcr 下。根据糖尿病状态,准确性的差异较小。在这些亚组和所有其他亚组中,eGFRcr-cys 的准确性与 eGFRcr 或 eGFRcys 相当或更准确。
在我们研究的大多数亚组中,eGFRcr-cys 比 eGFRcr 更准确,提示在测量血清胱抑素 C 作为确认性试验以获得更准确的 eGFR 时,优选使用 eGFRcr-cys。需要进一步研究以评估使用 eGFRcys 和 eGFRcr-cys 的诊断策略。